The most reliable diagnostic method for graft rejection is biopsy. Thus non-invasive markers of imminent rejection would be useful. Pteridines are secreted by activated lymphocytes (1 , 2) , and both serum and urina ry neopterin concentrations may rise prior to renal graft rejection (3) . Serum concentrations of ~z microglobulin (~2M) have also been shown to rise before rejection occurs clinically (4), whereas C-reactive protein (CRP) rises later in rejection and with bacterial infection (5).
We measured serum concentrations of creatinine and of neopterin, ~2 M and CRP by immunoassay in 30 consecutive patients undergoing renal transplantation . As inpatients, they had dail y serum samples taken and stored at -20°C. All episodes of graft dysfunction (i. e. persistent dialysis-dependence or a significant rise in serum creatinine) were investigated Data from all patients showed that serum concentrations of neopterin and ~2 M correlated with creatinine (r = 0.75 , P < 0.0001 and r = 0.65, P < 0.0001 respectively, n = 472) but there was no relationship between CRP and creatinine. Neopterin and ~2M were related (r = 0.64, P < 0.0001). In the 21 patients who had 37 renal biopsies performed, susta ined rises or fa lls (at least 3 out of 4 consecutive days) of the neopterin/creatinine ratio, ~2 M /creatinine or CRP prior to the biopsy were noted and related to whether the biopsy confirmed rejection or acute tubular necrosis (ATN). Changes in serum CRP concentration were entirely unrelated to rejection, whilst neopterin/ creatinine rose in 85% (p = 0.0025) of the episodes of rejection and 27% in ATN , but the false negative rate in rejection was 15 %. ~2 M /creatinine showed a si milar pattern , but with a 30% false negative rate. If either of these parameters were rising then the false negative rate was reduced to 12% (p = 0.0005).
Although the false negative rate shown here was only 12 -15% this is still unacceptable for a sole marker of rejection . However, by using both neopterin and ~2 M as adjuncts to normal monitoring techniques, the clinician may be able to diagnose rejection at an earlier and more readily reversible stage. Among several other causes, respiratory infections are speculated to be involved in the etiology of sudden infant death syndrome (SIDS). At necropsy we obtained urine and serum of 19 SIDS cases, all less than 8 months of age. In addition, we examined 59 serum and 35 urine specimens of 37 adults who died for various causes (mainly cardiac death) and did not show any signs of inflammatory disorders at necropsy; 28 serum and 14 urine specimens stem from 17 cases, who had obvious signs of inflammatory disorders at necropsy (10 infections, 5 carcinoma, 1 multiple trauma, 1 burn). We examined neopterin and creatinine concentrations in serum and urine using HPLC, and serum interferon-y by radioimmunoassay (Centocor). Serum neopterin and urine neopt~rin/creati nine from cases with inflammatory disorders and with SIDS were significantly higher compared to cases without signs of inflammation. Serum creatinine and interferon-y concentrations were indistinguishable, however, 11 / 14 SIOS cases had detectable interferony and 5 had concentrations 100 above U /L. Urine and serum neopterin correlated significantly to serum interferon-y levels. Serum neopterin (median: 77 nmol/L) and creatinine (median: 312 Ilmol/L) were extremely high in many samples, and serum samples obtained > 10 hours after death had significantly higher neopterin (z = 2.52, P = 0.12) and creatinine (z = 3.73, p < .001) than sera obtained earlier. Urine neopterin and serum interferon-y did not differ. These observations were confirmed in sequentially collected necropsy samples of a case who died after gun shot:
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Urine neopterinjcreatinine did not differ between 6 samples collected 4 -20 hours after death, bu t an immediate increase of serum neopterin and creatinine was observed within 8 -10 hours after death. Interferon-y raised to 167 U jL within the finil 6 hours and declined to normal thereafter. Obviously the interval between death and necropsy significantly influences serum but not urine neopterin levels. The reason for these changes in serum is not clear. Extremely high neopterin levels, which were observed in SIOS cases, favour the speculation that the etiology of the syndrome is linked to immune activation cascades, which may be related to e. g., respiratory infections. The ontogeny of the Mononuclear Phagocyte System (MPS) and especially its differentiation from circulating blood monocytes (MO) to mature tissue macrophages (MAC) is essential both for the phenotypic heterogeneity of the various cell populations within this family as well as for the functional competence of an individual cell in a given microenvironment. Thus, not only activating but also differentiation inducing signals determine the biology of individual MAC subtypes. Normal MO to MAC differentiation can be studied in vitro where blood MO transform to exudate-type MAC under appropriate conditions in the presence of serum (1) . Cells of the MPS participate in inflammation by releasing a variety of soluble mediators responsible for the pathophysiological processes occurring. We thus were interested in the dependence of constitutive and stimulated cytokine secretion on the stage of MAC differentiation in vitro. Elutriation-purified blood MO with a purity of > 95% as evident from cytochemistry and antigenic phenotype were cultured up to 28 days on hydrophobic Teflon foils. At various culture stages cells were harvested and 5 x lOs jml MAC were incubated in plastic dishes under serum-free conditions for 24 hours to analyze their secretory repertoire both constitutively, under stimulation with lipopolysaccharide (LPS) and interferon-gamma, respectively. In MAC conditioned supernatants, IL-1alpha and -beta and TNF-alpha was measured by ELISA technique, M-CSF (done by P. Ralph, Cetus, USA) and neopterin by RIA. IL-6 was determined with a sensitive bioassay using the B9 cell line. Furthermore, the cell-associated procoagulant activity (PCA) of MAC was also tested functionally.
Developmental Regulation of Stimulus Response and
For each of the cytokines tested and the PCA, a different pattern of regulation was observed. During the initial phase of maturation (up to day 7 in culture) within which the characteristics of normal MO to MAC transformation is achieved (2) in terms of morphology, expression of maturation-associated antigens (MAX antigens, CD 51, CD 16, CD 71) and cytochemistry, M-CSF was the only cytokine to be secreted constitutively. From the LPS-dependent cytokines, IL-l and IL-2 were downregulated whereas TNF-alpha levels increased about 6 to to-fold. Constitutive M-CSF secretion increased until day 7 in culture with LPS being stimulatory for this particular cytokine only for the first 3 -5 days in culture and then even suppressed the constitutive secretion. Interferon-gamma, in contrast, being only a weak stimulus for M-CSF in blood MO, became an effective stimulus in MO-derived MAC with a maximum release around day 7. Neopterin was dependent on IFN-gamma but also, though to a lesser extent, on LPS stimulation. Whereas freshly isolated blood MO only released small amounts of neopterin upon stimulation, its release was maximal around day 7 and decreased thereafter. About the same stimulus specificity and dependence on MAC maturation was found for expression of PCA. Only for the LPS-dependent cytokines I L-l , I L-6 and TNF -alpha, a synergistic effect of IFNgamma and LPS was observed. Upon further cultivation of MAC up to 28 days, IL-6 levels started to increase again to reach that of blood MO by day 28. However, IL-t secretion stayed very upon prolonged MAC culture whereas M-CSF remained high and TNF-alpha continued to raise reaching levels which were about 30 to 50-fold higher than in blood MO. In contrast, neopterin secretion returned to blood MO levels. Long-term cultured MAC started to secrete IL-6 and TNF-alpha even with adherence as the sole stimulus and, furthermore , became responsive to IFN-gamma alone.
These experiments document the great functional plasticity of human macrophages and their differential response to activation where each cytokine is independently regulated. The results may emphasize the impact of MO to MAC differentiation in vivo and may be of relevance for the understanding of normal macrophage physiology. However, the observation of the constitutive cytokine secretion in aged, long-term cultured MAC may also point to the role of MAC in chronic granulomatous disorders where overproduction of cytokines like TNF and IL-6 may occur. Further insights in the nature and determinants of this ongoing MAC differentiation process which 213 might be uncoupled from normal feedback regulation could lead not only to better understanding of chronic inflammation but may also help to design new concepts for therapy. Urinary neopterin has been indicated as a marker of cell-mediated immune system activation and therefore correlated to several diseases as viral infections, allograft rejections, autoimmune and malignant diseases and AIDS, in which cell mediated immune system is prominently involved (1) . In particular, we have already demonstrated in HIV positive children that urinary neopterin is closely correlated with the clinical course of the disease and inversely correlated with the CD4/CD8 ratio, therefore being a good prognostic parameter in the follow up of the infection. This study was aimed to assess if urinary neopterin can be utilized as a reliable parameter in monitoring HIV positive children undergoing Zidovudine (AZT) treatment.
Correlation Between Urinary Neopterin and
We have studied 7 HIV positive children, 4 males and 3 females, ranging in age between 4 months and 4 years-11 months (mean age 27.7 months), subdivided according to the CDC classification as follow s 4 children in P2a, 1 in P2ac and 2 in P2abd 1 d2d3f They were treated with AZT, 300 mg/mq/ 12 hourly os.
Neopterin values were determined by its native fluorescence by HPLC before starting treatment and 3 --iJ months later. Urate is the end product of purine metabolism in man. Loss of urate oxidase activity results in loss of urate breakdown to allantoin and further oxidation products and high urate levels are observed in plasma, CSF and gastric fluids. Urate can donate electrons and is a chain breaking antioxidant. Although other hydroxylated compounds have this ability, urate is important because of the high physiological levels (eg. in plasma up to 300 11M) and superior or equal antioxidant activity. Cutler (1) positively correlated the maximum lifespan potential of a variety of mammalian species with serum and brain urate levels. Ames et al. (2) proposed that urate is an important antioxidant in humans, offering protection against oxidant and radical-caused aging and cancer. There have been several reports that urate is positively correlated with intelligence (3, 4) and this hypothesis including a link with tetrahydrobiopterin (BH4) is discussed.
The activity of 5-methyltetrahydrofolate (5MeTHF) as a model for BH4 was measured in aqueous solutions and in human blood plasma by HPLC. In tap water (pH 7.3) 60 minutes after the initial injection 0% of 0.15 11M 5MeTHF was found. However in blood plasma (PH 7.4) 87% ± 11.8 (SD), n = 5, of 5MeTHF activity remained after 60 minutes. Degradation of 5MeTHF occurs rapidly in tap water by autoxidation (5) . In blood plasma however, protein, ascorbate and urate act as water soluble antioxidants to prevent folate degradation; anyone of these giving full antioxidant protection. A similar situation will occur with BH4 (5). Because of low protein and ascorbate contents in CSF higher urate levels become the major antioxidant defence.
A patient with severe neurological disease due to 5, 10-methylenetetrahydrofolate reductase deficiency (6) had normal serum BH4 levels, but lower BH4 than Depression is probably a CNS BH4 deficiency state. As BH4 levels are in excess of requirement early BH4 depletion is without effect; decreasing BH4 initially causes BH4 to be AAH and CA rate controlling producing mood fluctuations and latterly with severe BH4 reduction severe depression.
In neonates urinary Nand B did not correlate but urinary B and I did suggesting that as in active depression BH4 levels are rate controlling for AAH and CA activity.
Patients with methotrexate (MTX) had lowered urine I, suggesting reduced BH4 synthesis. This could be reversed by oral folates suggesting reduction of purine biosynthesis (2) . The effect of folates on depression patients may therefore be due to increased BH4 formation from an enlarged purine pool. The catabolism of folates is well established and is known to occur in a variety of mammalian species. The site of catabolic breakdown to inactive scission products is however a controversial issue. Research from our laboratory has suggested that the major site of catabolism is the gastrointestinal tract, particularly in the stomach (as a result of nitrite oxidation) with some breakdown possibly occurring in the lumen of the small intestine.
Oral dosing experiments in rats (n = 5) with mixed label folic acid (83 I-lg/Kg body weight) have identified a difference in the distribution of the two labels in urine and faeces 24 hours after administration. Significantly greater percentage 14C activity (faeces = 16.96 % ± 10.87; urine = 3.20% ± 0.58, p < 5%) was identified in faeces compared to urine. In urine however, a greater % of the total dose was found in the tritiated form (urine = 31.05% ± 5.89; faeces = 21.31 % ± 4.64, P < 5%). These results suggest a possible breakdown in the gut at the C9-NI0 position with greater proportions of unabsorbable 14C-pterins excreted in faeces while whole folates and tritiated scission products are absorbed and excreted in the urine (1).
Intestinal speciation experiments in vivo with tritiated folic acid also point to catabolism within the lumen of the gut (2) with greater scission being observed in the fed rat compared to the fasted. Evidence that the breakdown of folates is an oxidative process is from the simultaneous dosing of 5-methyltetrahydrofolate (5MeTHF) with ascorbate to man . Plasma kinetics indicate a 2 -3 fold rise in plasma 5MeTHF when dosed with ascorbate compared to without (3) . As an antioxidant, ascorbate promotes the entry of folates into the body by preventing oxidative breakdown in the gut. Similar work in rats dosing folic acid with the antioxidants vitamin E and diethylstilboestrol gave a decrease in the amount of urinary tritiated scission products compared to controls (1). Converse results are obtained when refined corn oil is dosed with folic acid. Refined corn oil contains large amounts of oxidising species having undergone lipid peroxidation. This increase in oxidising species cause a breakdown of folates with an increase in urinary scission products observed over a 72 hour period coupled with a concommittant decrease in the retention of liver folate (1).
Other workers have suggested that folate breakdown occurs intracellularly and our laboratory has tried several means to induce catabolism within the cell. The anti-epileptic drugs phenobarbitone and phenytoin are known to induce several microsomal mixed function oxidases. There was however, no increase in urinary tritiated folate catabolites after IP injection of these drugs followed by oral folates in rats (4) . Similarly irradiation, which produces oxidising species had no effect on the SMeTHF content of pigs liver as measured by HPLC (Farrar, unpublished observations).
Investigations into the oxidation of SMeTHF, the most prevalent mono/polyglutamate have noted its lack of stability in aqueous solutions but its persistence in food and the body. The stability of SMeTHF in various waters was examined by HPLC, (all results are expressed as a % of SMeTHF activity at t = 60 minutes compared to t = 0 minutes, n = S). Tap water (pH 7.3) was a particularly noxious solution for SMeTHF, since no folate was present at t = 60. At pH 2.3 however, SMeTHF was protonated at the NS region and this imparts a degree of stability on the molecule (60% ± 23). Distillation (8S% ± 19), treatment with activated charcoal (8S% ± 6.S), boiling (67% ± 14.6), boiling and displacement with inert gas (61 % ± 17) all impart further stability to SMeTHF as does using commercially available bottled water (8S% ± 11 .8) . These results suggest that a gaseous substance, probably chlorine is acting as the oxidising species. The formation of chlorine free radicals possibly in combination with molecular oxygen act to involve folates in a chain reaction, the termination product being 5-methyldihydrofolate.
The majority of folates are not present in simple aqueous solutions but in food and body fluids where a variety of species both protein and non-protein act upon folates. We examined a variety of antioxidants at physiological levels (;:::: 100 f.lM) and their capacity to limit 5MeTHF (O .lS f.lM) catabolism. All prevented 217 5MeTHF breakdown but to a varying degree -bovine serum albumin (97% ± 3.7), f)-lactoglobulin (92% ± 6.3), uric acid (80% ± 6.6), tyrosine (78 % ± 11.7), butylhydroxytoluene (64% ± 2.7), ascorbate (48% ± 5.6).
Although ascorbate is thought to be the primary plasma antioxidant to protect lipids from peroxidative damage (5), uric acid imparts a significantly greater antioxidant effect over SMeTHF than ascorbate. Similar results were recorded at 10 f.lM levels (uric acid = 54% ± 10.8; ascorbate = 11 % ± 3.4, P < 1 %).
Since uric acid is present at greater levels than ascorbate in plasma, CSF and gastric fluids , it may playa more important role than previously thought in preventing folate degradation .
The effects of the commonly occurring oxidant nitrite on 5MeTHF stability were also examined . Experiments at pH 2.3 and 7.3 were performed in di stilled water because of the previous oxidation of SMeTHF noted in tap water at neutral pH. At pH 7.3 a degree of stability is imparted over 5MeTHF (50% ± 11.8),
at pH 2.3 however, no signal is seen after 20 minutes (0%). The species thought to be responsible for acid mediated oxidation of folate is the protonated nitrite ion, H 2 0NO +.
The antioxidant properties of the six previously mentioned substances were all completely lost at acid pH in the presence of equimolar nitrite. Similarly a high molecular weight folic acid/ f)-lactoglobulin complex, 6S% of which persisted after incubation in human stomach fluids (pH 2.0) did not exist when further nitrite was added to the incubation. 100% of the complex existed after incubation in human small bowel fluids at pH 7.4 with and without the addition of nitrite emphasizing the importance of pH in thi s oxidative reaction.
In summary, the results of this paper suggest th .. ' major site of folate catabolism to be in the stomach. Intracellular breakdown in normal circumstances is largely discounted because of the presence of protei ns and other antioxidants in addition to certain enzymes (i. e. superoxide dismutase and glutathione peroxi · dase) limiting the number of intracellular oxidising species. The eventual breakdown of folate polyglutamates may be by returning them into the mono · glutamate pool via salivary and bile secretions, where they undergo breakdown in the same way that firstpass folates are catabolised. Uric acid may be a n important Hematopoietic disturbances are common in patients with human immunodeficiency virus type 1 (HIV-1) infection. Recent studies on immune activation markers such as neopterin demonstrate that HIV-l infection is associated with chronic immune activation. We investigated a possible association between the degree of immune activation and blood cell variables in 94 HIV-l seropositive individuals; 83 of them were Waiter Reed stage 1 or 2. Further, we compared the in vitro IL-2 production of T-cells of the latter patients with serum neopterin concentrations. Serum neopterin concentrations were determined by radioirn-munoassay and compared to cell counts (CD4+ Tcells, white blood cells, platelets, red blood cells) and to hemoglobin, hematocrit and mean corpuscular volume. In vitro IL-2 production was measured from peripheral blood mononuclear cells (PBMC) in response to stimulation with soluble antigens (influenza A virus, tetanus toxoid) and alloantigens. Significant negative correlations existed between neopterin concentrations and hemoglobin, hematocrit and platelets (p < 0.001). These correlations were also significant if only WRl and WR2 patients were considered for calculations. In addition, higher neopterin concentrations were associated with reduced in vitro responsiveness of cells to antigenic stimulation whereas individuals with lower neopterin levels showed normal in vitro response. We conclude that hematologic abnormalities and reduced in vitro responsiveness of PBMC are associated with chronic immune activation in patients with HIV -1 infection. Our data support the concept that activated immune cells and specific cytokines such as interferon gamma and tumor necrosis factor alpha are able to inhibit bone marrow hematopoiesis. Defective in vitro production of cytokines by T-lymphocytes may be a consequence of chronic immune activation in vivo.
Immune Associated Neopterin and Kynurenine Changes in CSF of Lyme Neuroborreliosis Patients
2 ), L. Hagberg2), G. In patients with burns, neopterin levels have not been reported so far. Neopterin levels might be altered through toxins formed during the injury, by alloantigens upon transplantation of allogeneic skin or through antigens during infections.
Therefore, we measured serum neopterin by radioimmunoassay in 25 consecutive patients with burns of 6-82% (mean 28 .5%) total body surface area. Highly variable neopterin levels were found in these patients during hospitalization . Neopterin increased to well above the upper normal limit of 9 nmol/I within the first 2 days after burn injury; maximum levels were about 600 nmol/1.
Treatment included in all cases early (on day 3-5) and repetitive operations and skin transplantations (split-thickness skin, either autologous, homologous, or mixed), but no immunosuppressive therapy. Direct influences of transplantations or infections (elevated body temperature and leukocyte counts) on serum neopterin from 3 days before to 3 -5 days after the events were not found. Patients were grouped according to burnt body surface < 20%, 20-50% , and > 50%, resp. ; however, no significant influence of burnt body surface area on neopterin levels was seen during follow-up .
To exclude renal insufficiency as a possible cause of elevated neopterin levels in these patients, serum creatinine was determined and the neopterin/creatinine ratio calculated; there was practically no influence observed. Abstracts: Ninth Winter Workshop on Pteridincs mortality risk (1) . Neopterin levels in this group of patients are significantly higher in the first week after the trauma than in those with the index < 80.
In patients recovering from burns, serum neopterin levels normalized. In the 6 patients who died subsequently of multiorgan failure due to sepsis, neopterin levels were highly increasing from about ten days before death. It can be concluded that the T ceil-monocyte/ macrophage axis is highly activated in patients with burns. The initial and presumably rate limiting enzyme in many mammals in the de novo pathway of BH4-synthesis is guanosine triphosphate cyclohydrolase I (GTP-CH, EC 3.5.4.16). This enzyme converts GTP into dihydroneopterintriphosphate, an intermediate which is also involved in monapterin biosynthesis . BH4 can be found in most tissues of mammalian species, but the capacity varies widely among different tissues. High activities of GTP-CH are generally found in tissues with high requirements for BH4. We reported about remarkedly high concentrations of biopterin and monapterin in the retina and suggested a yet unknown role of pterins in retinal function . To study the capacity of pterin biosynthesis we determined GTP-CH activity by means of neopterin synthesis from GTP. Crude extracts of neuroretina and retinal pigment epithelium (RPE) of bovine eyes were used . Higher enzyme activity in RPE than in the neuroretina was found , a result which parallels our determinations of oxidized pterins in these tissues. High levels of oxidized monapterin in the retina may furthermore require a considerable retinal enzyme activity, that forms monapterin from neopterin.
GTP-CH-Activity in Bovine Retina

Reduction of Ferric Ion by Reduced Pteridines
A . Hausen Cytomegalovirus (CMV) infection is potentially hazardous to transfusion recipients especially when they are immunocompromized. Acute CMV infection leads to the development of CMV IgM antibodies. Later IgM is lost and IgG appears in the circulation. However, the phase of acute viraemia prior to seroconversion is not detectable by antibody tests.
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Thus, blood, which is potentially contaminated with an infectious agent such as CMV, may be transfused despite the use of specific tests. In a group of 1109 random donors we tested for acute CMV infection using CMV IgM ELISA (Behring, Abbott). In addition, CMV IgM positive donations were tested for rheumatoid factor, heterophilic antibodies, and Epstein Barr Virus infection. Seventeen (1.53%) had neopterin concentrations > 10 nmol/ L (Henning), one of them was CMV IgM positive. 3/ to92 with neopterin concentrations below the cut-off level were CMV IgM positive. CMV IgM positivity was significantly more likely in donors with neopterin concentrations > to nmol/ L (odds ratio = 22.69, p = 0.002). We further tested 1.767 of 93.789 donations (1.88%) during 1. 1. 1988-31. 12. 1989, who had neopterin concentrations> 10 nmol/L, for CMV IgM. 103 were found to be seropositive. Control samples could be taken from most of them to test for the development of CMV IgG. Furthermore, we found 10 cases, who developed CMV IgM after they presented with neopterin concentrations> 10 nmol/ L at donation . Concomitantly with the appearance of CMV IgM in the circulation, neopterin concentrations decreased; they were normal, when CMV IgG became detectable. CMV viraemia was detected by high neopterin concentrations 2 -3 weeks prior to antibody detection. Thus, the 3 CMV IgM positive donors with neopterin concentrations < to nmol / L (as described above) are likely to represent an end stage of acute CMV infection. It remains to be shown, whether higher neopterin levels reflect higher antigenic load and infectivity. The data support the view that neopterin screening of blood donations increases safety in transfusion medicine. neopterin was independent from dose and duration of therapy (P > 0.1), although the majority of patients showed slightly increasing neopterin concentrations 12-18 months after therapy was started compared to the concentrations found in the earlier phases of therapy. In total, 9/14 neopterin concentrations decreased more than 20% compared to pretreatment levels, 4/ 14 remained stable (within ± 20%) and only 1/14 increased above 125% within the first 6 months of therapy. The neopterin changes were accompanied by clinical improvement in most of the patients. In conclusion, the beneficial effects of Zidovudine therapy in patients with HIV-1 infection are reflected by decreasing neopterin concentrations. The neopterin data also indicate that chronic immune activation is being reduced by treatment with Zidovudine.
Neopterin Changes during Zidovudine Treatment
Urinary Neopterin in Glomerulonephritis
L. Leohinm 1l , T. Pholcharoenl), V. fold when compared to healthy subjects have been found in SLE, FSGS and IgM nephropathy patients respectively. In contrast, neopterin levels in membranous and IgA nephropathy patients did not differ from the normal subjects. It is of interest that neopterin levels in 5 SLE patients with clinically inactive disease were normal or slightly increased. In addition. there was no correlation between the degree of neopterin levels and nephrotic syndrome or proteinuria . The present study showed that it seemed to be reasonable to explain that cell mediated immunity might play an important role in most patients with glomerulonephritis. However, further studies are required to see whether the degree of neopterin levels can be used as one of the parameters for differentiating glomerulonephritis according to histopathological classification and for indicating the activity of the diseases. The pathogenesis of dementive illness in HIV -1 infection still remains to be elucidated. Tryptophan was found to be reduced in sera and CSF of HIV-infected patients, the clinical relevance remains to be investigated. In vitro data showed that neopterin release is paralleled by the induction of indoleamine (2,3)-dioxygenase (100) which degrades tryptophan to kynurenine. We were interested to investigate a possible association between disturbed tryptophan metabolism, chronic immune stimulation and neuropsychiatric symptoms in HIV -1 infection.
Tryptophan and Neopterin Metabolism in Patients with
Serum tryptophan, kynurenine and neopterin concentrations were measured by HPLC in 25 HIV -1-infected patients (all male; median age 34.0 yr). Dementia was diagnosed by using a structured interview whose diagnostic algorithm is based on reliable (DSM-III-R) criteria and which provides quantification of results (score 0 -55).
Patients with dementia had lower serum tryptophan levels compared to those HIV-infected individuals without such symptom. Tryptophan and neopterin levels were inversely correlated (r = -.66). Both were correlated with the dementia score (neopterin: r = -.50, P = 0.02; tryptophan: r = .42, P = 0.06).
Reduced tryptophan levels are very likely to result from persistent immune activation. This is underlined by their strong negative correlation. The significant correlation with neopterin levels and dementia score may indicate that chronic immune stimulation is involved in the disturbed tryptophan metabolism and the pathogenesis of neuropsychiatric symptoms of HIV-l infection. , an analysis was performed investigating a potential value of the post-transplant neopterin concentrations for prediction of graft survival. Three variables were extracted from the neopterin data: a) the mean neopterin concentration, b) the maximum neopterin concentration, and c) the mean neopterin concentration during the last week of the post-transplant stay. Information was incorporated in the analysis regarding age at transplantation, sex, modality of immunosuppression, and experience of rejection and/or infection episodes during the post-transplant stay. Starting point for the analysis was discharge from the hospital, end point was time of nephrectomy. By product-limit analysis, the following factors were associated with significantly poorer prognosis of graft survival: maximum neopterin above 800 ~mol /mol creatinine (third quartile; p = 0.0003), rejection episode(s) during posttransplant stay (p = 0.0008), age below 37 yr (median; p = 0 .0012) and mean neopterin above 400 ~mol /mol creatinine (third quartile; p = 0.0023) . Multivariate analysis including all variables identified three jointly significant variables: age (p = 0.0014), maximum neopterin (p = 0.0083) and rejection episode(s)
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(p = 0.020). The contributions of these factors to the hazard function were of similar magnitude: 2.1 for age, 1.9 for neopterin, and 1.7 for rejection(s). A model was constructed using the number of these risk factors as grouping variable. A product limit analysis with this model yielded a highly significant discrimination between high-risk and low-risk patients (Chisquare with 3 d. f. = 33.9, p = 2 X 10-7 ) . Thus, urinary neopterin during post-transplant time in recipients of kidney allografts is not only a significant marker for acute immunological problems, it is also a significant determinant of long-term graft survival. Severe multiple trauma is defined as an injury which affects more than one body region and the whole pattern of lesions leads to unstability of vital functions. Immune deterioration is an observation frequently made in this group of trauma patients. Delayed complications are seen quite often in these patients and feature multiple organ failure and/or sepsis, and thus contribute to high morbidity and mortality. It seems to be reasonable that immune activation is responsible for this development. Serum neopterin concentrations were reported to be increased in such patients and to provide predictive information with respect to outcome. In a preliminary study we investigated 6 consecutive patients with severe multiple trauma. The Injury Severity Score at admission had to be more than 30 points for inclusion. The course of the patients was observed daily by following scoring systems: APACHE 2, MOF score (Goris), SEPSIS score (Elebute, Stoner), PIF score (PIF is a measure of the force of respirator setting), Quotient (a relative AaD02) and daily maximum temperature. Urinary neopterin levels were measured daily by HPLC. Radioimmunoassays were used for measurements of serum neopterin (Henning, FRG), beta-2-microglobulin (Pharmacia, S) and interferon-gamma (Centocor, USA, optimized for increased sensitivity) every other day. In ali patients we found an increase of interferongamma with a peak at the third day followed by a decrease to normal levels. The altitude of this peak correlated with blood loss and with the amount of blood given to a patient immediately after traum a.
Course of Immune Activation Markers in Patients after
Subsequently to the peak of interferon gamma we observed a slow but steady increase of neopterin and beta-2-microglobulin. Serum and urine neopterin concentrations on day 6 correlate best with the serum interferon-gamma concentrations on day 3 (r, > .95 , p < .01). Beta-2-microglobulin also correlates with PIF Associations can also be observed between SEP-SIS score, urinary neopterin, and serum neopterin. However, we could not find any connection to other clinical variables. The small number of patients investigated hitherto does not allow the make definite statistical statements. But it seems worthwile to confirm the connections trauma/ bloodloss/ blood transfusion /activation of the immune system/clinical sco res in a more extended study. i. The Crithidia fas ciculata assay (1) uses the growth factor properties of B (and some closely related pterins); however it is laborious and not specific. ii . By HPLC and fluorescence detection B can be measured together with most other pterins. Electrochemical detection allows also direct measurement of reduced biopterins (2) . A radioimmunoassay (RIA) for B has been reported (3), but its work-up procedure renders it unsuitable for routine use.
Tetrahydrobiopterin BH4 is the cofactor of aroma tic amino acid hydroxylases. In body fluids, its oxidation products dihydrobiopterin (BH 2 ) and B occur normally only in small amounts; BH4 is degraded rather than oxidized. Therefore, with all methods for B determination, precautions in obtaining and storing samples are necessary, as well as a chemical oxidation converting the reduced forms definitively to B. Thi s is in contrast to neopterin (N) determinations, where in serum ca. 1/ 3 of total N occurs in the fully oxidized form . In our RIA a highly specific biopterin sheep antiserum is used (cross-reactivities to structurally related pterins, e. g. BH 2 , BH 4 , N , sepiapterin , monapterin, 6-hydroxymethylpterin are negligible) together with an iodine-125-labelled B as tracer (3 , 4) . Reduced pterins are oxidized for 1 hour with acidic iodine; after addition of ascorbic acid, neutralisation and dilution, these samples are used directly in the RIA (4).
RIA procedure: 20 III (or 100 III after oxidation) of sample or standard (0 -729 nmol/I) are incubated for 2 h at room temperature with 100 III of antiserum (preprecipitated 1 st/2nd antibody complex) and 100 III of tracer (approx. 40000 cpm). After addition of washing solution and centrifugation, the supernatant is decanted. The sensitivity of the assay is approx . 1 nmol/1.
In normal human serum no B was detected . After oxidation, total B levels were found to be 4.8 ± 0.9 nmol /I (n = 9) in accordance with published values.
This assay for convenient determination of biopterin, or total B after oxidation, may help, together with the respective neopterin assay, to further elucidate and establish the role of these pterins in biochemistry and immunology.
content in tissue. We have examined the kynurenine, P-5-P and catecholamines concentration of isolated frog heart tissue 30 min after the addition of Dneopterin, 7,8-dihydroneopterin and 5,6,7 ,8-tetrahydrobiopterin (Dr. B. Schircks, Switzerland) to incubation medium in the concentration of 4 flmol /I and 20 nmol /!. Control heart tissue has been examined 30 min after using only the incubation medium for coldblooded animals. The addition of 7,8-dihydroneopterin and 5,6,7 ,8-tetrahydrobiopterin to incubation medium followed both, by the increase of kynurenine and P-5-P content in isolated heart tissue. In cases with biopterin we have observed some elevation of the dopamine and the adrenaline concentration, too. D-Neopterin increased the kynurenine and the noradrenaline content but decreased the P-5-P and the dopamine content in isolated heart tissue. In the ultrastructure of some cardiomyocytes we have shown the supercontraction of myofibrils and oedema of mitochondria in cases with D-neopterin. These preliminary data allow us to suggest that D-neopterin promotes the host defence reaction as well as the calcium accumulation in cells and calcium-dependent cell dystrophy induced by kynurenine. The time courses of IFN-gamma (IFN-g) , neoptcrin (NPT) and the soluble IL-2 receptor (IL-2R) were measured in serum of twelve adults after vaccination with vaccinia virus. Nine individuals had been vacciniated against smallpox in early childhood (group 1), the remaining three persons underwent smallpox vacciniation for the first time in life (group 2). Blood samples were taken daily from the day of vaccination (day 0) to day 4 and on day 7 and stored in aliquots at -70°C.
A dramatic rise ofIFN-g with peak levels> 2000 U / I occurred on day 4 in all the three group 2 persons. This rise was accompanied by a constant increase of NPT from < 2 ng/ml to > 6 ng/ml between day 4 and day 7. In addition, these persons developed strong skin reactions and got fever between day 4 and day 7. Group 1 persons showed a different pattern: levels 225 of IFN-g and NPT increased on day 3 and on day 4 and had returned to normal on day 7. In seven individuals IFN -g increased by 50 -150 U /1 and NPT by 0.3 -1.5 ng/m!. In two individuals however, these increases were much more pronounced (IFN-g: 500 and 800 U /1, NPT: 3.1 and 3.4 ng/ml); this was accompanied by stronger immunologic reactions (swollen Iymphnodes, pustules) as compared to the other members of group 1. In contrast to group 2 members these persons did not develop fever. Finally IL-2R levels increased by 100 -130 U /ml in five group 1 and by 130 -300 U /ml in all group 2 members between day 4 and day 7.
Taken together, those persons vaccinated for the first time in life showed strong increases of IFN-g and NPT which correlated well with their immunologic reactions. The time courses of these two serum parameters were significantly different between the two groups of vaccinated persons (p < 0.005) whereas changes in IL-2R levels were both less pronounced and less significant. The 2-ring carbon of histidine is metabolized by folate dependent enzymes. The objective of these studies was to determine the distribution of the single carbon atoms in folate coenzymes which are derived from the 2-ring carbon of histidine. A rat was injected intravenously with 100 flCi of [2-ring 14C] histidine. After 2.5 minutes the liver was removed, extracted , and the folylpolyglutamates separated by chromatography on DEAE-cellulose. The fractions were counted, and assayed using Lactobacillus casei and Streptococcusfaecalis which permitted differentiation between methyland formyl-H 4 folates. Radioactivity from the ring carbon histidine was found mainly in the methyl-H 4 folate fraction . The p4C] labeling of the methyl-H 4 folates was at least five times greater, on a molar basis, than that of the formyl-H 4 folates. Identification of [14C] labeled methyl group was established by conversion of the methyl group to p4C] labeled formaldehyde by methylene-H 4 folate reductase [EC 1.1.99.15). Since formyl-H 4 folates are first on the metabolic pathway in the conversion of the formimino group of formiminoglutamic acid (FIGLU) derived from the ring carbon of histidine, one would expect the formyl-H 4 folates to be more highly labeled than the methyl-H 4 folates. The low labeling of formyl-H 4 folates suggests compartmentalization in which only a small part of the formyl-H 4 folates participates in the metabolism of FIGLU. This is consistent with the observation that most of the formyl-H 4 folates are in the mitochondria while most of the methyl-H 4 folates are in the cytosol (1, 2) . It was also found that nitrous oxide treatment, which increases the proportion of methyl-H 4 folates, changed the folates in the cytosol without affecting those in the mitochondria (1) . This suggests the existence of different pools of folates with are not in rapid equilibrium with each other. Formiminotransferase (EC 2.1.2.5) and methylene-H 4 folate reductase are cytosolic enzymes. It seems possible that labeled formyl-H 4 folate formed from [2-ring 14C] histidine would be in equilibrium with the smaller cytosolic pool and would be greatly diluted by the larger pool of unlabeled formyl-H 4 folates in the mitochondria. Labeled methyl-H 4 folates formed in the cytosol would be only minimally diluted by the smaller pools in the mitochondria.
Interferon-gamma is one of the many lymphokines mainly produced by T lymphocytes in response to antigenic or mitogenic stimulation, and plays a key role in regulating the immune system. We recently developed a new anti-interferon-gamma monoclonal antibody (MAb), named IGMB-14, which unlike all previous anti-interferon-gamma MAbs, recognizes in Western blot two polypeptides (MW 28 .000 and 56.000) present in two different affinity-purified interferon-gamma preparations without reacting with the interferon-gamma subspecies (namely MW 25 .000 and 20.000) whose molecular weight is already known (1).
An immunofluorescence assay was then developed to evaluate the expression of these new interferongamma subspecies on the surface of circulating lymphocytes, using MAb IGMB-14 and flow cytometry
Abstracts: Ninth Winter Workshop on Pteridines (1). We discovered that, the expression of interferongamma on lymphocytes marks activated T-cells both in vitro (1) and in vivo (2) . When lymphocytes from 111 patients (with various infectious diseases) and 40 healthy subjects were studied for interferon-gamma expression, out of 64 patients with proven acute viral infections 59 were found to have a significantly higher percentage of lymphocytes expressing interferongamma than the healthy subjects. Yet, only 3 (8 .9%) out of 34 patients with proven bacterial infections had an increased percentage of interferon-gamma positive lymphocytes. None of the 8 patients with fungal infections or of the 5 with LES showed an increased percentage of positive interferon-gamma lymphocytes. In addition, the percentage of interferongamma-expressing lymphocytes during viral infection was found to vary with the stage of disease (2) . Lymphocytes expressing interferon-gamma on their surface were evaluated in 61 IVDA patients infected with HIV-l, and in 85 healthy subjects (61 blood donors and 24 HIV-l seronegative IVDA). Interferongamma-expressing lymphocytes, mostly CD8 positive cells, were found in the HIV -1 infected patients: their percentage was always higher in such patients than in the healthy individuals (p < 0.001) and increased with the progressive stages of HIV-l infection. Three AIDS patients were monitored for over four months and immediately showed a very high percentage of interferon-gamma-positive lymphocytes in blood samples, which remained such even in a blood sample obtained from one patient just a few days before his death and revealed in these patients, at least chronic and persistent in vivo activation of cell mediated immunity.
As a self recognized substance in the human immune system, interferon-gamma should elicit human antibodies only as a consequence of autoimmune disorders, or following the injection of molecules whose structure and antigenicity have been modified by various mechanisms. We recently reported the presence of natural interferon-gamma antibodies in sera from healthy individuals, assayed both by RIA and Western blot. On the other hand , sera from virus-infected patients were discovered to contain high titers of antiinterferon-gamma antibodies, according to the stage of disease, with levels highest at the onset of symptoms and gradually decreasing as the disease resolved (3). When purified by affinity column , these anti-interferon-gamma antibodies were observed to neutralize the immunomodulating activity of interferon-gamma. The titre of anti-interferon-gamma antibodies was found to be very high both in healthy HIV-seropositive patients and in LAS and AIDS patients (4) . When the titre of anti-interferon-gamma antibodies was compared with the percentage of interferon-gamma-expressing lymphocytes during acute vira l infection, a strong correlation was discovered between the two parameters. No correlation was found in healthy HIV seropositive IVDA and LAS, while it was found in AIDS patients. In conclusion, if antiinterferon-gamma antibodies exert feedback control on interferon-gamma production , with suppressive activity on the Iymphokine, the mechanism appears to be deregulated in HIV-infected patients from the beginning of HIV-1 infection.
We recently found that HIV -1 expresses interferongamma molecules on its surface (5), with a mechanism never yet described for other viruses. AIDS is caused by HIV infection and is primarily a disease of the immune system. Our data clearly show a qualitative, rather than a quantitative, defect in the immune system with progressive and persistent activation of celImediated immunity and deregulation of the interferon-gamma-anti-interferon-gamma Ab system in HIV infected patients. To what extent these phenomena are due to the presence of interferon-gamma on the surface of HIV particles or to other mechanisms, remains a matter for further investigation. In humans, increased concentrations of neopterin have been observed in body fluids of patients with diseases challenging the cell mediated immunity (1) . In other species except primates, however, comparable concentrations of neopterin have never been found , neither in healthy nor in immunologically challenged animals.
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We investigated the biochemical background of these observations using cultured human fibroblasts , macrophages, THP-1 myelomonocytoma and T 24 bladder carcinoma cells and , for comparison, murine macrophages, macrophage cell lines and dermal fibroblasts. We studied intracellular and extracellular pteridine concentrations, GTP-cyclohydrolase I (EC 3.5.4.16), 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase (EC 1.1.1.153) activities. After appropriate incubation of protein fractions of cells with precursors, the formed pteridines were quantified using a special solid phase extraction on-line elution HPLC-system (2).
Interferon-gamma increases GTP-cyclohydrolase I activities 7 to 40 fold in all four investigated human cells in a dose-and time-dependent manner. Activity reaches 0.4 to 4 pmol mg -I min-I , starts to increase after 6 to 9 h and reaches a plateau after 24 to 30 h. 6-Pyruvoyltetrahydropterin synthase (0 .1 to 7 pmol mg I min -I) and sepiapterin reductase (250 to 1000 pmol mg , l min -I) are constitutively present in the cells and are not influenced by the interferon treatment. Both, intracellular and extracellular pteridine concentrations rise severalfold after treatment with interferon-gamma. Ratios of neopterin to biopterin thus formed vary from 50 : 1 for macro phages and THP-l cells, 1 : 4 for fibroblasts and 1 : 50 for T 24 cells . This ratio of neopterin to biopterin is determined by the activity of the induced GTP-cyclohydrolase T relative to the constitutive 6-pyruvoyltetrahydropterin synthase . Formation of neopterin is most pronounced in stimulated human macrophages, where a GTPcyclohydrolase I activity of 4 pmol mg " 1 min 1 is coupled to only 0.1 pmol mg 1 min -1 of 6-pyruvoyltetrahydropterin synthase. In contrast, in T 24 cells 6-pyruvoyltetrahydropterin synthase is 7.7 pmol mg 1 min -I, and action of interferon-gamma stimulates the GTP-cyclohydrolase I activity from 0.19 to 1.35 pmol mg 1 min -I. Thus , tetrahydrobiopterin is synthesized in human T 24 cells without accumulation of neopterin derivatives.
In murine fibroblasts , pteridine synthesis is stimulated by tumor necrosis factor alpha in a manner similar to interferon-gamma in human fibroblasts . Only the GTP-cyclohydrolase I activity is increased up to 3 pmol mg -I min -I, 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase are constitutively present. Murine macrophages and macrophage Jines show constitutive pteridine synthesis, (GTP-cyc1ohy-drolase I 3 to 6 pmol mg I min I) which cannot be increased further by cytokines. Due to the two orders of magnitude higher 6-pyruvoyltetrahydropterin synthase activities in murine cells (25 to 65 pmol mg 1 min 1) as compared to the human cells, tetrahydro-biopterin is synthesized in murine cells without accumulation of neopterin derivatives. In cells of both species, man and mouse, cytokine treatment yields increased concentrations of tetrahydrobiopterin.
In murine fibroblasts we were able to demonstrate by inhibition and reconstitution of pteridine synthesis, that the tetrahydrobiopterin formed upon cytokine treatment provides an essential cofactor for the oxidation of arginine to citrulline and nitric oxide. This reaction, which has thus far been described for murine macro phages and for endothelial cells, has recently been shown to be pteridine dependent (3). three interferons is enhanced by co-treatment with TNF-alpha. LPS induces both pathways and costimulates the effect of interferon-gamma in a dosedependent manner. These data demonstrate that THP-l shows many features of normal monocytes/ macrophages concerning pteridine synthesis and tryptophan degradation and can therefore serve as an in vitro model for studying these metabolic actions of interferon-gamma. Neopterin concentrations decreased during antituberculous therapy.
Is Neopterin Helpful in Distinguishing Between
Specific diagnosis of tuberculosis in AIDS patients is difficult. We conclude that neopterin could be a diagnostic aid in discriminating HIV related tuberculosis. Neopterin levels reflect disease activity of tuberculosis and can thus be a potential tool to determine the duration of antituberculous therapy in HIV infection. The identification/isolation of pteridines present in biological materials require a potent analytical method, ego rp-HPLC on C I8 -ODS using 3 -15 mM potassium phosphate buffer containing 0 -25% methanol (flow rate, 1 mIJmin). -We studied the influence of the pH of the eluent (range, pH 3 -11) on some parameters (fluorescence, retention time, separation) of 22 pteridines. -The separation of yellow fluorescing pterins was achieved with a 4 mM phosphate buffer (pH 6) containing 15% methanol (xanthopterin , X; 3' -hydroxysepiapterin; sepiapterin) and 25% methanol (deoxysepiapterin), respectively. -For most of the blue fluorescing pteridines we used aqueous buffers (pH 4 -11). 6-, 7-pterincarboxylic acid, 7-hydroxylumazine (7-HL), neopterin (6-N), monapterin (M), biopterin (6-B), isoxanthopterin (I), 6-hydroxymethylpterin (6-HMP) and pterin (P) were well separated with a pH 4.5-buffer. A pH 6.3-eluent (increased fluorescence: biolumazine, BL; 6-hydroxyluminazine, 6-HL; X) was successfully used to quantitate 6-HL, 6-N, M , X and BL whereas 6-B and 7-B (= 7-iso-biopterin, L-primapterin) were co-eluted with L and I, respectively. Here, an addition of 3% methanol to the pH 6-buffer resulted in a separation of I from 6-BJ7-B/L (fused peaks) and allowed the quantitation of the sharp and resolved peaks of 6-N, M, I, 6-HMP and P (eg, urine analyses)! -A separation of L from B as well as of the isomers of neopterin (6-N; 7-N = 7-iso-neopterin = D-anapterin) and of biopterin (6-B; 7-B) was accomplished with a pH 7.5-buffer which was also suitable for the quantitation of strongly fluorescent X and BL. -At pH 7, 6-formylpterin (6-FP), 6-methylpterin (6-MP) and 6,7-dimethylpterin (6,7-DMP) were eluted in broad peaks at higher retention times (RT, ;::=: 25 min , ;::=: 50 min and ;::=: 150 min, resp.) than the aforementioned pteridines. The isolation of 6-FP was im-a manifestation of tumors in Beagle dogs (eg, after bone marrow transplantation, bmt) and the urinary excretion (nmol/mmol creatinine x 1 urine) of pteridines (eg, biopterin). Because of its concentration, (catheter-) urine was used and monitored (rp-HPLC) (3, 4) for more than 2 years. Healthy Beagles (n = 4) presented a total biopterin, 6-B, of 880 nmol (SD, ± 280); reduced portion, 90-95 % (oxidized/unoxidized urine). At pH 7.6, a small peak separated from 6-B. It was co-eluted with authentic L-primapterin (7-iso-biopterin; 7-B) and indicates possibly the presence of both isomers to 36 mmol/l urine (n = 295), with a "normal" mean (n = 202) of 5.5 mmol/l (SD, ± 3.1). The main pterins found were 6-B (total, 1200 nmol; SD, ± 600) and isoxanthopterin, I (580 nmol; SD, ± 340). The mean of the reduced portion of 6-B was 65% (SD, ± 10%; n = 27). Pterin (low level; unspecific alterations) was excluded as parameter. In most of the monitored Beagles, 6-B and I exhibited a nearly analogous excretion. Interestingly, in some cases (eg, after manifestation of thyroid gland carcinoma) a strong increase of 6-B was observed at a relatively constant I. To evaluate a predictive value of B/I-analyses, further studies are necessary using a less invasive method, ego the monitoring of plasmatic B and I with the micromethod (100 -200 l.tI of plasma/serum) as described in (3) in combination with a high-sensitive fluorescence monitor (eg, Shimadzu RF-535). Additionally, all supernatants contained 6-hydroxymethylpterin, which was lacking in the culture medium used.
